Indian Generics Maker Sun Pharma Recalls ED Meds in the U.S. Post author:PacConAdmin Post published:November 22, 2021 Post category:Drug Industry Daily Indian Generics Maker Sun Pharma Recalls ED Meds in the U.S. Source: Drug Industry Daily You Might Also Like Reforms Needed in FDA Advisory Committee Process, Says Former AdComm Member August 23, 2022 Ascendis Hit With CRL Over Variability in Delivered Dose in Drug/Device Combo May 1, 2023 J&J Settles Thousands of Risperdal Cases, Says SEC Filing November 1, 2021
